title: Primary cutaneous Epstein-Barr virus-associated B-cell lymphoma arising at the site of subcutaneous injections of methotrexate.
authors.affiliation: Angers University Hospital, Angers, France.
authors.forename: Carole
authors.initials: C
authors.lastname: Giard
authors.forename: Martine
authors.initials: M
authors.lastname: Avenel-Audran
authors.forename: Anne
authors.initials: A
authors.lastname: Croué
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Verret
authors.forename: Ludovic
authors.initials: L
authors.lastname: Martin
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D003879:Dermatologic Agents / Q000009:adverse effects; D003882:Dermatomyositis / Q000188:drug therapy; D020031:Epstein-Barr Virus Infections / Q000150:complications* / Q000473:pathology; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007150:Immunohistochemistry; D016393:Lymphoma, B-Cell / Q000139:chemically induced* / Q000473:pathology / Q000821:virology*; D008727:Methotrexate / Q000009:adverse effects*; D011239:Prednisolone / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000473:pathology / Q000821:virology*
chemical_list: D000305:Adrenal Cortex Hormones; D003879:Dermatologic Agents; D016756:Immunoglobulins, Intravenous; D011239:Prednisolone; D008727:Methotrexate